Both are weekly injectables in the GLP-1 family, but tirzepatide acts on a second hormone pathway that semaglutide does not. Here is the difference, explained without the hype — and why the choice is a provider’s call.
Titration is the slow, stepwise dose increase at the start of GLP-1 treatment. Understanding why providers climb gradually — and how it is personalized — makes the first months far less mysterious.
The articles on this blog are general education, not medical advice. Treatment is available only where legally available and only if a licensed provider determines it is appropriate after review; a prescription is never guaranteed, availability varies by state and provider review, and individual results vary. Back to all articles.
